2.2. PHYSICAL AND PHYSICOCHEMICAL METHODS

<1117> MICROBIOLOGICAL BEST LABORATORY …

708 〈1117〉 Microbiological Best Laboratory Practices / General Information USP 35 glassware or from prior materials used in the glassware. Be Media should be labeled properly with batch or lot num-

  Practices, Laboratory, 1117 gt microbiological best laboratory, 1117, Microbiological, Best, 1117 microbiological best laboratory practices

<1227> VALIDATION OF MICROBIAL RECOVERY …

USP 35 General Information / 〈1227〉 Validation of Microbial Recovery 883 〈1227〉 VALIDATION OF culture preparation. The conditions of organism preparation and storage must be standardized for the neutralizer evalua-MICROBIAL RECOVERY FROM tion and should reflect the conditions of the antimicrobial

  Validation, Recovery, Microbial, 1227 gt validation of microbial recovery, 1227, 1227 validation of microbial recovery

2.2.32. LOSS ON DRYING - 药物在线-快捷药物信息 …

2.2.33. Nuclear magnetic resonance spectrometry EUROPEAN PHARMACOPOEIA 7.0 01/2009:20233 2.2.33. NUCLEAR MAGNETIC RESONANCE SPECTROMETRY INTRODUCTION Nuclearmagneticresonance(NMR)spectrometryisananalytical

  Resonance

2.2.46. CHROMATOGRAPHIC SEPARATION …

2.2.45. Supercritical fluid chromatography EUROPEAN PHARMACOPOEIA 7.0 Control solutions.In addition to the TOC water control, prepare suitable blank solutions or other solutions needed for establishing the baseline or for calibration adjustments

  Chromatography

2.6.12. MICROBIOLOGICAL - DrugFuture

2.6.12. Microbial enumeration tests EUROPEAN PHARMACOPOEIA 7.0 Table 2.6.12.-1. – Preparation and use of test micro-organisms Growth …

  Microbiological, Preparation

2.4. LIMIT TESTS - DrugFuture

EUROPEAN PHARMACOPOEIA 7.0 2.4.4. Chlorides 2.4. LIMIT TESTS 01/2008:20401 2.4.1. AMMONIUM Unlessotherwiseprescribed,usemethodA. METHOD A ...

  Tests, Limits, Limit tests

EUROPEAN PHARMACOPOEIA 7 - DrugFuture

2.2.25. Absorption spectrophotometry, ultraviolet and visible EUROPEAN PHARMACOPOEIA 7.0 acquired using suitable purged instruments or ensuring that sample and background single beam spectra are acquired under

  European, Pharmacopoeia, Absorption, Absorption spectrophotometry, Spectrophotometry, European pharmacopoeia

5.1.3. EFFICACY OF ANTIMICROBIAL PRESERVATION

EUROPEAN PHARMACOPOEIA 7.0 5.1.3. Efficacy of antimicrobial preservation suspensions may be presented in sealed ampoules. Biological indicators are prepared in such a way that they can be stored

  Preservation, Antimicrobial, Efficacy, Efficacy of antimicrobial preservation

<1151> PHARMACEUTICAL DOSAGE FORMS - …

766 〈1151〉 Pharmaceutical Dosage Forms / General Information USP 35 Figure 1. Compendial Taxonomy for Pharmaceutical Dosage Forms. volumes recommended in the accompanying table are usu- Identification—Identification tests are discussed in the

  Form, Pharmaceutical, Dosage, 1115, 1151 gt pharmaceutical dosage forms, 1151 pharmaceutical dosage forms

2.9.40. UNIFORMITY OF DOSAGE UNITS - …

2.9.40. Uniformity of dosage units EUROPEAN PHARMACOPOEIA 7.0 Table 2.9.40.-1. – Application of Content Uniformity (CU) and Mass Variation (MV) test for dosage forms Dosage forms Type Sub-Type Dose and ratio of active substance

  Unit, Dosage, Uniformity, Uniformity of dosage units

Total protein (serum, plasma)

© Copyright Association for Clinical Biochemistry 2012 Total protein (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte

  Total, Protein, Serum, Plasma, Total protein

2.2.2. DEGREE OF COLORATION OF LIQUIDS - …

EUROPEAN PHARMACOPOEIA 6.0 2.2.2. Degree of coloration of liquids solutions) prescribed in the monograph. Compare the colours in diffused daylight, viewing horizontally against a

  Liquid, Degree, Degree of coloration of liquids, Coloration

2.2.2. DEGREE OF COLORATION OF LIQUIDS - …

EUROPEAN PHARMACOPOEIA 7.0 2.2.2. Degree of coloration of liquids Titration. Place in a 250 mL conical flask fitted with a ground-glassstopper,10.0mLofthesolution,15mLofwaterR,

  Liquid, Degree, Degree of coloration of liquids, Coloration

Immunoglobulins (IgG, IgA, IgM)

Immunoglobulins (IgG, IgA, IgM) General Information IgA: raised in elderly, chronic infection, cirrhotic liver disease. IgM: raised primary biliary cirrhosis, acute infection, EBV, CMV, TB.

  Immunoglobulin

Women’s Health Test Reference Guide - Quest …

At Quest Diagnostics, we help ensure that you provide the best possible care to your patients. • Access a full range of tests, from the routine to the

  Health, Guide, Tests, Reference, Women, Quest diagnostics, Quest, Diagnostics, Women s health test reference guide

How to Measure Sulphate - CWC

HP Training Module File: “ 45 How to Measure Sulphate.doc” Version: September 2000 Page 2 1. Module context This module deals with the significance of sulphate to …

  Measure, Sulphate, How to measure sulphate

Complement determinations in human disease - …

Another assay system uses rate nephelometry. This tech-nique takes advantage of the fact that the interaction of antigen and antibody in solution leads to the formation of a

  Human, Disease, Determination, Complement, Complement determinations in human disease, Nephelometry

PA Criteria - Universal American Medicare

Updated 08/01/2018 2 Prior Authorization Group ADEMPAS Drug Names ADEMPAS Covered Uses All FDA-approved indications not otherwise excluded from Part D. Exclusion Criteria